Siemens Healthineers (SHL.DE) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $51.14B | Exchange | XETRA |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | DE | CEO | Bernhard Montag |
| IPO Date | 2018-04-12 | CAGR | 6.1% |
| Employees | 74,300 | Website | www.siemens-healthineers.com |
| Div. Yield | 1.26% | Payout Ratio | 51% |
| Buy Back Yield | 0.22% | Total Yield | 1.48% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $62.28B | P/E | 16.8 | Forward P/E | 16.47 | PEG | 0.88 |
| P/S | 3.81 | P/B | 4.62 | P/CF | 29.09 | P/FCF | 39.73 |
| Sales | $26.70B | Sales 1Y | -0.92% | Sales 3Y | 7.14% | Sales 5Y | 38.66% |
| EPS | $2.72 | EPS 1Y | 2.59% | EPS 3Y | 38.09% | EPS 5Y | 24.53% |
| Sales QoQ | 1.48% | EPS QoQ | 33.33% | Sales QoQ Avg | 0.93% | EPS QoQ Avg | 7.37% |
| Gross Margin | 39.02% | Operating Margin | 14.84% | Profit Margin | 9.55% | ROCE | 10.46% |
| ROA | 5% | ROE | 12% | Altman Z Score | 1.93 | Piotroski Score | 9 |
| Current Ratio | 1.16 | Quick Ratio | 0.8 | Cash Ratio | 0.18 | Op. CF Ratio | 0.09 |
| Debt/Equity | 0.79 | Debt/Assets | 0.33 | Lt Debt/Equity | 0.6 | Lt Debt/Cap. | 0.37 |
| Intrst Cov. | 8.45 | Inventory Turnover | 2.99 | Asset Turnover | 0.51 | Receivables Turnover | 3.45 |
| Enterprise Value | $62.28B | P/E Ratio | 16.8 |
| Forward P/E | 16.47 | PEG Ratio | 0.88 |
| P/S Ratio | 3.81 | P/B Ratio | 4.62 |
| P/CF Ratio | 29.09 | P/FCF Ratio | 39.73 |
| EPS | $2.72 | EPS Growth 1Y | 2.59% |
| EPS Growth 3Y | 38.09% | EPS Growth 5Y | 24.53% |
| Revenue Growth 1Y | -0.92% | Gross Margin | 0.39% |
| Operating Margin | 0.15% | Profit Margin | 0.1% |
| ROE | 0.12% | ROA | 0.05% |
| ROCE | 0.1% | Current Ratio | 1.16 |
| Quick Ratio | 0.8 | Cash Ratio | 0.18 |
| Debt/Equity | 0.79 | Interest Coverage | 8.45 |
| Altman Z Score | 1.93 | Piotroski Score | 9 |
Siemens Healthineers (SHL.DE) valuation & financials
Siemens Healthineers (SHL.DE) has a market capitalization of 51.14B EUR and trades at a price-to-earnings ratio of 16.8. It operates in the Healthcare sector (Medical - Devices).
Siemens Healthineers's revenue grew -0.9% over the last year.
Siemens Healthineers's next earnings report is scheduled for November 5, 2026; analysts estimate EPS of 0.79 EUR. Check the earnings calendar to see all companies reporting this week.
Siemens Healthineers (SHL.DE) — frequently asked questions
When does Siemens Healthineers (SHL.DE) report earnings next?
Siemens Healthineers is expected to report earnings on November 5, 2026. Analysts estimate EPS of 0.79 EUR.
What is Siemens Healthineers's market cap?
Siemens Healthineers (SHL.DE) has a market capitalization of 51.14B EUR.
What is SHL.DE's P/E ratio?
Siemens Healthineers trades at a price-to-earnings ratio of 16.8, with trailing twelve-month EPS of 2.72 EUR.
How fast is Siemens Healthineers growing?
Siemens Healthineers's revenue grew -0.9% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)